# Curcumin (Diferuloylmethane Derivative) With or Without Bioperine in Patients With Multiple Myeloma

> **NCT00113841** · NA · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 42 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Curcumin
- **DRUG:** Bioperine

## Key facts

- **NCT ID:** NCT00113841
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11
- **Primary completion:** 2009-08
- **Final completion:** 2009-08
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2011-11-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00113841

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00113841, "Curcumin (Diferuloylmethane Derivative) With or Without Bioperine in Patients With Multiple Myeloma". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00113841. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*